MediciNova Announces Abstract Regarding Results of a

LA JOLLA, Calif., April 02, 2024 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and...

Related Keywords

United States ,Tokyo ,Japan ,Chicago ,Illinois ,American ,Gilbert Youssef ,Geoff Obrien ,Oncology At Dana Farber Cancer Institute ,Exchange Commission ,American Society Of Clinical Oncology ,Physician At Harvard Medical School ,Nasdaq ,Medicinova Inc ,Standard Market ,Tokyo Stock Exchange ,Code Number ,American Society ,Clinical Oncology ,Annual Meeting ,Attending Physician ,Harvard Medical School ,Dana Farber Cancer Institute ,Rapid Oral Abstract ,Central Nervous System ,Private Securities Litigation Reform Act ,Nasdaq Mnov ,Medicinova ,Nc ,